{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:29:56Z","timestamp":1789471796030,"version":"build-2803163510"},"reference-count":200,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"ANRF-PAIR Project JNU-PAIR Network on Science for Sustainable Future","award":["ANRF\/PAIR 2025\/000029\/PAIR"],"award-info":[{"award-number":["ANRF\/PAIR 2025\/000029\/PAIR"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s10072-026-08834-7","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T06:27:42Z","timestamp":1772260062000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Unravelling the novel insights between miR-7 and Parkinson\u2019s disease (PD)"],"prefix":"10.1007","volume":"47","author":[{"given":"Sakshi","family":"Kushwaha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Lakhanpal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Elangovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahalaxmi","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arul","family":"Narayanasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dibbanti Harikrishna","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zothan","family":"Siama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukesh Kumar","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6863-0170","authenticated-orcid":false,"given":"Balachandar","family":"Vellingiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,28]]},"reference":[{"key":"8834_CR1","doi-asserted-by":"publisher","unstructured":"Elangovan A, Venkatesan D, Selvaraj P et al MiRNA in Parkinson\u2019s disease: from pathogenesis to theranostic approaches. J Cell Physiol n\/a : https:\/\/doi.org\/10.1002\/jcp.30932","DOI":"10.1002\/jcp.30932"},{"key":"8834_CR2","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrm3838","volume":"15","author":"M Ha","year":"2014","unstructured":"Ha M, Kim VN (2014) Regulation of MicroRNA biogenesis. Nat Rev Mol Cell Biol 15:509\u2013524. https:\/\/doi.org\/10.1038\/nrm3838","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8834_CR3","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton AB, Farrer M, Johnson J et al (2003) \u03b1-Synuclein locus triplication causes Parkinson\u2019s disease. Science 302:841\u2013841. https:\/\/doi.org\/10.1126\/science.1090278","journal-title":"Science"},{"key":"8834_CR4","doi-asserted-by":"publisher","unstructured":"Vellingiri B, Balasubramani K, Iyer M et al Role of telomeres and telomerase in Parkinson\u2019s Disease\u2014A new theranostics? Advanced Biology n\/a:2300097. https:\/\/doi.org\/10.1002\/adbi.202300097","DOI":"10.1002\/adbi.202300097"},{"key":"8834_CR5","doi-asserted-by":"publisher","first-page":"9799","DOI":"10.1523\/JNEUROSCI.1787-16.2017","volume":"37","author":"DJ Surmeier","year":"2017","unstructured":"Surmeier DJ, Obeso JA, Halliday GM (2017) Parkinson\u2019s disease is not simply a prion disorder. J Neurosci 37:9799\u20139807. https:\/\/doi.org\/10.1523\/JNEUROSCI.1787-16.2017","journal-title":"J Neurosci"},{"key":"8834_CR6","doi-asserted-by":"publisher","unstructured":"Fouka M, Mavroeidi P, Tsaka G, Xilouri M (2020) In search of effective treatments targeting \u03b1-Synuclein toxicity in synucleinopathies: pros and cons. Front Cell Dev Biol 8. https:\/\/doi.org\/10.3389\/fcell.2020.559791","DOI":"10.3389\/fcell.2020.559791"},{"key":"8834_CR7","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1056\/NEJMct1208070","volume":"367","author":"MS Okun","year":"2012","unstructured":"Okun MS (2012) Deep-brain stimulation for Parkinson\u2019s disease. N Engl J Med 367:1529\u20131538. https:\/\/doi.org\/10.1056\/NEJMct1208070","journal-title":"N Engl J Med"},{"key":"8834_CR8","doi-asserted-by":"publisher","first-page":"134625","DOI":"10.1016\/j.chemosphere.2022.134625","volume":"301","author":"B Vellingiri","year":"2022","unstructured":"Vellingiri B, Suriyanarayanan A, Selvaraj P et al (2022) Role of heavy metals (copper (Cu), arsenic (As), cadmium (Cd), iron (Fe) and lithium (Li)) induced neurotoxicity. Chemosphere 301:134625. https:\/\/doi.org\/10.1016\/j.chemosphere.2022.134625","journal-title":"Chemosphere"},{"key":"8834_CR9","doi-asserted-by":"publisher","first-page":"102171","DOI":"10.1016\/j.arr.2023.102171","volume":"94","author":"A Elangovan","year":"2024","unstructured":"Elangovan A, Dahiya B, Kirola L et al (2024) Does gut brain axis has an impact on Parkinson\u2019s disease (PD)? Ageing Res Rev 94:102171. https:\/\/doi.org\/10.1016\/j.arr.2023.102171","journal-title":"Ageing Res Rev"},{"key":"8834_CR10","doi-asserted-by":"publisher","unstructured":"Babu HWS, Elangovan A, Iyer M et al (2023) Association study between kynurenine 3-Monooxygenase (KMO) gene and Parkinson\u2019s disease patients.\u00a0Mol Neurobiol.\u00a0 https:\/\/doi.org\/10.1007\/s12035-023-03815-9","DOI":"10.1007\/s12035-023-03815-9"},{"key":"8834_CR11","doi-asserted-by":"publisher","unstructured":"Venkatesan D, Iyer M, Narayanasamy A et al (2020) Kynurenine pathway in Parkinson\u2019s disease\u2014An update. eNeurologicalSci 21:100270. https:\/\/doi.org\/10.1016\/j.ensci.2020.100270","DOI":"10.1016\/j.ensci.2020.100270"},{"key":"8834_CR12","doi-asserted-by":"publisher","first-page":"107873","DOI":"10.1016\/j.pharmthera.2021.107873","volume":"227","author":"A Bortolozzi","year":"2021","unstructured":"Bortolozzi A, Manashirov S, Chen A, Artigas F (2021) Oligonucleotides as therapeutic tools for brain disorders: focus on major depressive disorder and Parkinson\u2019s disease. Pharmacol Ther 227:107873. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107873","journal-title":"Pharmacol Ther"},{"key":"8834_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.biocel.2015.11.001","volume":"69","author":"J Horsham","year":"2015","unstructured":"Horsham J, Ganda C, Kalinowski F et al (2015) MicroRNA-7: a miRNA with expanding roles in development and disease. Int J Biochem Cell Biol 69:215\u2013224. https:\/\/doi.org\/10.1016\/j.biocel.2015.11.001","journal-title":"Int J Biochem Cell Biol"},{"key":"8834_CR14","doi-asserted-by":"publisher","first-page":"107153","DOI":"10.1016\/j.compbiolchem.2019.107153","volume":"83","author":"F Khani-Habibabadi","year":"2019","unstructured":"Khani-Habibabadi F, Askari S, Zahiri J et al (2019) Novel BDNF-regulatory MicroRNAs in neurodegenerative disorders pathogenesis: an in Silico study. Comput Biol Chem 83:107153. https:\/\/doi.org\/10.1016\/j.compbiolchem.2019.107153","journal-title":"Comput Biol Chem"},{"key":"8834_CR15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nrm3313","volume":"13","author":"V Rottiers","year":"2012","unstructured":"Rottiers V, N\u00e4\u00e4r AM (2012) Micrornas in metabolism and metabolic disorders. Nat Rev Mol Cell Biol 13:239\u2013250. https:\/\/doi.org\/10.1038\/nrm3313","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8834_CR16","doi-asserted-by":"publisher","first-page":"5731","DOI":"10.1074\/jbc.M804280200","volume":"284","author":"RJ Webster","year":"2009","unstructured":"Webster RJ, Giles KM, Price KJ et al (2009) Regulation of epidermal growth factor receptor signaling in human cancer cells by MicroRNA-7*. J Biol Chem 284:5731\u20135741. https:\/\/doi.org\/10.1074\/jbc.M804280200","journal-title":"J Biol Chem"},{"key":"8834_CR17","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.bbadis.2011.02.002","volume":"1812","author":"MJ Bueno","year":"2011","unstructured":"Bueno MJ, Malumbres M (2011) Micrornas and the cell cycle. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1812:592\u2013601. https:\/\/doi.org\/10.1016\/j.bbadis.2011.02.002","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"key":"8834_CR18","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrm2868","volume":"11","author":"M Inui","year":"2010","unstructured":"Inui M, Martello G, Piccolo S (2010) Microrna control of signal transduction. Nat Rev Mol Cell Biol 11:252\u2013263. https:\/\/doi.org\/10.1038\/nrm2868","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8834_CR19","doi-asserted-by":"publisher","first-page":"a008144","DOI":"10.1101\/cshperspect.a008144","volume":"7","author":"KN Ivey","year":"2015","unstructured":"Ivey KN, Srivastava D (2015) MicroRNAs as developmental regulators. Cold Spring Harb Perspect Biol 7:a008144. https:\/\/doi.org\/10.1101\/cshperspect.a008144","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"8834_CR20","unstructured":"Jauhari A (2024) Differentiation induces dramatic changes in MiRNA Profile, where loss of Dicer diverts differentiating SH-SY5Y cells toward senescence"},{"key":"8834_CR21","doi-asserted-by":"publisher","first-page":"96","DOI":"10.2174\/18715273113126660190","volume":"13","author":"T Singh","year":"2024","unstructured":"Singh T, Jauhari A, Pandey A et al (2024) Regulatory triangle of Neurodegeneration, adult neurogenesis and MicroRNAs. CNS Neurol Disorders - Drug Targets 13:96\u2013103","journal-title":"CNS Neurol Disorders - Drug Targets"},{"key":"8834_CR22","doi-asserted-by":"publisher","first-page":"734","DOI":"10.4103\/1673-5374.353481","volume":"18","author":"Z-X Ma","year":"2023","unstructured":"Ma Z-X, Liu Z, Xiong H-H et al (2023) MicroRNAs: protective regulators for neuron growth and development. Neural Regeneration Res 18:734. https:\/\/doi.org\/10.4103\/1673-5374.353481","journal-title":"Neural Regeneration Res"},{"key":"8834_CR23","doi-asserted-by":"publisher","first-page":"C3","DOI":"10.1152\/ajpcell.00022.2019","volume":"317","author":"Q Ma","year":"2019","unstructured":"Ma Q, Zhang L, Pearce WJ (2019) Micrornas in brain development and cerebrovascular pathophysiology. Am J Physiol Cell Physiol 317:C3\u2013C19. https:\/\/doi.org\/10.1152\/ajpcell.00022.2019","journal-title":"Am J Physiol Cell Physiol"},{"key":"8834_CR24","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.yexcr.2013.09.022","volume":"321","author":"R Petri","year":"2014","unstructured":"Petri R, Malmevik J, Fasching L et al (2014) Mirnas in brain development. Exp Cell Res 321:84\u201389. https:\/\/doi.org\/10.1016\/j.yexcr.2013.09.022","journal-title":"Exp Cell Res"},{"key":"8834_CR25","doi-asserted-by":"publisher","first-page":"14825","DOI":"10.1523\/JNEUROSCI.1611-13.2013","volume":"33","author":"K F\u00e9nelon","year":"2013","unstructured":"F\u00e9nelon K, Xu B, Lai CS et al (2013) The pattern of cortical dysfunction in a mouse model of a schizophrenia-related microdeletion. J Neurosci 33:14825\u201314839. https:\/\/doi.org\/10.1523\/JNEUROSCI.1611-13.2013","journal-title":"J Neurosci"},{"key":"8834_CR26","doi-asserted-by":"publisher","first-page":"e2813","DOI":"10.1038\/cddis.2017.214","volume":"8","author":"P Chmielarz","year":"2017","unstructured":"Chmielarz P, Konovalova J, Najam SS et al (2017) Dicer and micrornas protect adult dopamine neurons. Cell Death Dis 8:e2813\u2013e2813. https:\/\/doi.org\/10.1038\/cddis.2017.214","journal-title":"Cell Death Dis"},{"key":"8834_CR27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41393-018-0180-1","volume":"57","author":"T Zhang","year":"2019","unstructured":"Zhang T, Ni S, Luo Z et al (2019) The protective effect of microrna-21 in neurons after spinal cord injury. Spinal Cord 57:141\u2013149. https:\/\/doi.org\/10.1038\/s41393-018-0180-1","journal-title":"Spinal Cord"},{"key":"8834_CR28","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0960-9822(02)00809-6","volume":"12","author":"M Lagos-Quintana","year":"2002","unstructured":"Lagos-Quintana M, Rauhut R, Yalcin A et al (2002) Identification of tissue-specific micrornas from mouse. Curr Biol 12:735\u2013739. https:\/\/doi.org\/10.1016\/S0960-9822(02)00809-6","journal-title":"Curr Biol"},{"key":"8834_CR29","doi-asserted-by":"publisher","first-page":"R13","DOI":"10.1186\/gb-2004-5-3-r13","volume":"5","author":"LF Sempere","year":"2004","unstructured":"Sempere LF, Freemantle S, Pitha-Rowe I et al (2004) Expression profiling of mammalian MicroRNAs uncovers a subset of brain-expressed MicroRNAs with possible roles in murine and human neuronal differentiation. Genome Biol 5:R13. https:\/\/doi.org\/10.1186\/gb-2004-5-3-r13","journal-title":"Genome Biol"},{"key":"8834_CR30","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12935-015-0259-0","volume":"15","author":"J Zhao","year":"2015","unstructured":"Zhao J, Tao Y, Zhou Y et al (2015) MicroRNA-7: a promising new target in cancer therapy. Cancer Cell Int 15:103. https:\/\/doi.org\/10.1186\/s12935-015-0259-0","journal-title":"Cancer Cell Int"},{"key":"8834_CR31","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3390\/ph14020149","volume":"14","author":"E Gajda","year":"2021","unstructured":"Gajda E, Grzanka M, Godlewska M, Gawel D (2021) The role of miRNA-7 in the biology of cancer and modulation of drug resistance. Pharmaceuticals (Basel) 14:149. https:\/\/doi.org\/10.3390\/ph14020149","journal-title":"Pharmaceuticals (Basel)"},{"key":"8834_CR32","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1016\/j.ymthe.2017.08.017","volume":"25","author":"KJ McMillan","year":"2017","unstructured":"McMillan KJ, Murray TK, Bengoa-Vergniory N et al (2017) Loss of microRNA-7 regulation leads to \u03b1-synuclein accumulation and dopaminergic neuronal loss in vivo. Mol Ther 25:2404\u20132414. https:\/\/doi.org\/10.1016\/j.ymthe.2017.08.017","journal-title":"Mol Ther"},{"key":"8834_CR33","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.celrep.2014.04.003","volume":"7","author":"A Pollock","year":"2014","unstructured":"Pollock A, Bian S, Zhang C et al (2014) Growth of the developing cerebral cortex is controlled by microRNA-7 through the p53 pathway. Cell Rep 7:1184\u20131196. https:\/\/doi.org\/10.1016\/j.celrep.2014.04.003","journal-title":"Cell Rep"},{"key":"8834_CR34","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.chemosphere.2019.05.064","volume":"233","author":"B Li","year":"2019","unstructured":"Li B, Jiang Y, Xu Y et al (2019) Identification of miRNA-7 as a regulator of brain-derived neurotrophic factor\/\u03b1-synuclein axis in atrazine-induced Parkinson\u2019s disease by peripheral blood and brain microRNA profiling. Chemosphere 233:542\u2013548. https:\/\/doi.org\/10.1016\/j.chemosphere.2019.05.064","journal-title":"Chemosphere"},{"key":"8834_CR35","doi-asserted-by":"publisher","first-page":"15669","DOI":"10.1073\/pnas.0605781103","volume":"103","author":"H-J Lee","year":"2006","unstructured":"Lee H-J, Palkovits M, Young WS (2006) MiR-7b, a microRNA up-regulated in the hypothalamus after chronic hyperosmolar stimulation, inhibits Fos translation. Proc Natl Acad Sci USA 103:15669\u201315674. https:\/\/doi.org\/10.1073\/pnas.0605781103","journal-title":"Proc Natl Acad Sci USA"},{"key":"8834_CR36","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s12975-021-00981-7","volume":"14","author":"SL Mehta","year":"2023","unstructured":"Mehta SL, Chokkalla AK, Bathula S, Vemuganti R (2023) MicroRNA miR-7 is essential for post-stroke functional recovery. Transl Stroke Res 14:111\u2013115. https:\/\/doi.org\/10.1007\/s12975-021-00981-7","journal-title":"Transl Stroke Res"},{"key":"8834_CR37","doi-asserted-by":"publisher","first-page":"eaat4285","DOI":"10.1126\/scisignal.aat4285","volume":"11","author":"T Kim","year":"2018","unstructured":"Kim T, Mehta SL, Morris-Blanco KC et al (2018) The MicroRNA miR-7a-5p ameliorates ischemic brain damage by repressing \u03b1-synuclein. Sci Signal 11:eaat4285. https:\/\/doi.org\/10.1126\/scisignal.aat4285","journal-title":"Sci Signal"},{"key":"8834_CR38","first-page":"993","volume":"8","author":"S Li","year":"2016","unstructured":"Li S, Lv X, Zhai K et al (2016) MicroRNA-7 inhibits neuronal apoptosis in a cellular Parkinson\u2019s disease model by targeting Bax and Sirt2. Am J Transl Res 8:993\u20131004","journal-title":"Am J Transl Res"},{"key":"8834_CR39","doi-asserted-by":"publisher","first-page":"13052","DOI":"10.1073\/pnas.0906277106","volume":"106","author":"E Junn","year":"2009","unstructured":"Junn E, Lee K-W, Jeong BS et al (2009) Repression of \u03b1-synuclein expression and toxicity by microRNA-7. Proc Natl Acad Sci U S A 106:13052\u201313057. https:\/\/doi.org\/10.1073\/pnas.0906277106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8834_CR40","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1749-6632.2000.tb06900.x","volume":"920","author":"MG Spillantini","year":"2000","unstructured":"Spillantini MG, Goedert M (2000) The \u03b1-Synucleinopathies: Parkinson\u2019s disease, dementia with lewy bodies, and multiple system atrophy. Ann N Y Acad Sci 920:16\u201327. https:\/\/doi.org\/10.1111\/j.1749-6632.2000.tb06900.x","journal-title":"Ann N Y Acad Sci"},{"key":"8834_CR41","doi-asserted-by":"publisher","first-page":"a009399","DOI":"10.1101\/cshperspect.a009399","volume":"2","author":"L Stefanis","year":"2012","unstructured":"Stefanis L (2012) \u03b1-Synuclein in Parkinson\u2019s disease. Cold Spring Harb Perspect Med 2:a009399. https:\/\/doi.org\/10.1101\/cshperspect.a009399","journal-title":"Cold Spring Harb Perspect Med"},{"key":"8834_CR42","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.nbd.2017.07.018","volume":"109","author":"C Peng","year":"2018","unstructured":"Peng C, Gathagan RJ, Lee VM-Y (2018) Distinct \u03b1-Synuclein strains and implications for heterogeneity among \u03b1-Synucleinopathies. Neurobiol Dis 109:209\u2013218. https:\/\/doi.org\/10.1016\/j.nbd.2017.07.018","journal-title":"Neurobiol Dis"},{"key":"8834_CR43","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.bbapap.2019.05.003","volume":"1867","author":"K Afitska","year":"2019","unstructured":"Afitska K, Fucikova A, Shvadchak VV, Yushchenko DA (2019) \u03b1-Synuclein aggregation at low concentrations. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1867:701\u2013709. https:\/\/doi.org\/10.1016\/j.bbapap.2019.05.003","journal-title":"Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"},{"key":"8834_CR44","doi-asserted-by":"publisher","first-page":"4499","DOI":"10.1021\/bi602461y","volume":"46","author":"ACM Ferreon","year":"2007","unstructured":"Ferreon ACM, Deniz AA (2007) \u03b1-Synuclein multistate folding thermodynamics: implications for protein misfolding and aggregation. Biochemistry 46:4499\u20134509. https:\/\/doi.org\/10.1021\/bi602461y","journal-title":"Biochemistry"},{"key":"8834_CR45","doi-asserted-by":"publisher","unstructured":"Recasens A, Perier C, Sue CM (2016) Role of MicroRNAs in the regulation of \u03b1-Synuclein expression: A systematic review. Front Mol Neurosci 9. https:\/\/doi.org\/10.3389\/fnmol.2016.00128","DOI":"10.3389\/fnmol.2016.00128"},{"key":"8834_CR46","doi-asserted-by":"publisher","first-page":"12726","DOI":"10.1074\/jbc.M109.086827","volume":"285","author":"E Doxakis","year":"2010","unstructured":"Doxakis E (2010) Post-transcriptional regulation of \u03b1-Synuclein expression by mir-7 and mir-153. J Biol Chem 285:12726\u201312734. https:\/\/doi.org\/10.1074\/jbc.M109.086827","journal-title":"J Biol Chem"},{"key":"8834_CR47","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1007\/s13311-021-01130-6","volume":"18","author":"J Zhang","year":"2021","unstructured":"Zhang J, Zhao M, Yan R et al (2021) MicroRNA-7 protects against neurodegeneration induced by \u03b1-Synuclein preformed fibrils in the mouse brain. Neurotherapeutics 18:2529\u20132540. https:\/\/doi.org\/10.1007\/s13311-021-01130-6","journal-title":"Neurotherapeutics"},{"key":"8834_CR48","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1212\/CPJ.0000000000000831","volume":"11","author":"L Cook","year":"2021","unstructured":"Cook L, Schulze J, Kopil C et al (2021) Genetic testing for Parkinson disease. Neurol Clin Pract 11:69\u201377. https:\/\/doi.org\/10.1212\/CPJ.0000000000000831","journal-title":"Neurol Clin Pract"},{"key":"8834_CR49","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.parkreldis.2021.10.001","volume":"92","author":"L Cook","year":"2021","unstructured":"Cook L, Schulze J, Verbrugge J et al (2021) The commercial genetic testing landscape for Parkinson\u2019s disease. Parkinsonism Relat Disord 92:107\u2013111. https:\/\/doi.org\/10.1016\/j.parkreldis.2021.10.001","journal-title":"Parkinsonism Relat Disord"},{"key":"8834_CR50","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00702-023-02612-x","volume":"130","author":"T Gasser","year":"2023","unstructured":"Gasser T (2023) Genetic testing for Parkinson\u2019s disease in clinical practice. J Neural Transm 130:777\u2013782. https:\/\/doi.org\/10.1007\/s00702-023-02612-x","journal-title":"J Neural Transm"},{"key":"8834_CR51","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/0024-3205(89)90519-5","volume":"45","author":"K Suda","year":"1989","unstructured":"Suda K, Takahashi H, Fukase N et al (1989) Distribution and molecular forms of glucagon-like peptide in the dog. Life Sci 45:1793\u20131798. https:\/\/doi.org\/10.1016\/0024-3205(89)90519-5","journal-title":"Life Sci"},{"key":"8834_CR52","doi-asserted-by":"publisher","first-page":"556","DOI":"10.22038\/ijbms.2020.41638.9832","volume":"23","author":"M Rameshrad","year":"2020","unstructured":"Rameshrad M, Razavi BM, Lalau J-D et al (2020) An overview of glucagon-like peptide-1 receptor agonists for the treatment of metabolic syndrome: a drug repositioning. Iran J Basic Med Sci 23:556\u2013568. https:\/\/doi.org\/10.22038\/ijbms.2020.41638.9832","journal-title":"Iran J Basic Med Sci"},{"key":"8834_CR53","doi-asserted-by":"publisher","first-page":"4223","DOI":"10.1172\/JCI78371","volume":"124","author":"LL Baggio","year":"2014","unstructured":"Baggio LL, Drucker DJ (2014) Glucagon-like peptide-1 receptors in the brain: controlling food intake and body weight. J Clin Invest 124:4223\u20134226. https:\/\/doi.org\/10.1172\/JCI78371","journal-title":"J Clin Invest"},{"key":"8834_CR54","doi-asserted-by":"publisher","first-page":"5149","DOI":"10.1210\/en.2003-0323","volume":"144","author":"L Farilla","year":"2003","unstructured":"Farilla L, Bulotta A, Hirshberg B et al (2003) Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. Endocrinology 144:5149\u20135158. https:\/\/doi.org\/10.1210\/en.2003-0323","journal-title":"Endocrinology"},{"key":"8834_CR55","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.3892\/mmr.2018.9180","volume":"18","author":"Y Yang","year":"2018","unstructured":"Yang Y, Fang H, Xu G et al (2018) Liraglutide improves cognitive impairment via the AMPK and PI3K\/Akt signaling pathways in type 2 diabetic rats. Mol Med Rep 18:2449\u20132457. https:\/\/doi.org\/10.3892\/mmr.2018.9180","journal-title":"Mol Med Rep"},{"key":"8834_CR56","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/nm919","volume":"9","author":"MJ During","year":"2003","unstructured":"During MJ, Cao L, Zuzga DS et al (2003) Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nat Med 9:1173\u20131179. https:\/\/doi.org\/10.1038\/nm919","journal-title":"Nat Med"},{"key":"8834_CR57","doi-asserted-by":"publisher","first-page":"T31","DOI":"10.1530\/JOE-13-0221","volume":"221","author":"C H\u00f6lscher","year":"2014","unstructured":"H\u00f6lscher C (2014) Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases. J Endocrinol 221:T31\u2013T41. https:\/\/doi.org\/10.1530\/JOE-13-0221","journal-title":"J Endocrinol"},{"key":"8834_CR58","doi-asserted-by":"publisher","first-page":"6275","DOI":"10.1016\/S0021-9258(17)37366-0","volume":"269","author":"K Adelhorst","year":"1994","unstructured":"Adelhorst K, Hedegaard BB, Knudsen LB, Kirk O (1994) Structure-activity studies of glucagon-like peptide-1. J Biol Chem 269:6275\u20136278. https:\/\/doi.org\/10.1016\/S0021-9258(17)37366-0","journal-title":"J Biol Chem"},{"key":"8834_CR59","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neuroscience.2016.03.056","volume":"325","author":"AH Dyer","year":"2016","unstructured":"Dyer AH, Vahdatpour C, Sanfeliu A, Tropea D (2016) The role of Insulin-Like growth factor 1 (IGF-1) in brain development, maturation and neuroplasticity. Neuroscience 325:89\u201399. https:\/\/doi.org\/10.1016\/j.neuroscience.2016.03.056","journal-title":"Neuroscience"},{"key":"8834_CR60","doi-asserted-by":"crossref","unstructured":"Gonzalez-Franquesa A, Patti M-E (2017) Insulin resistance and mitochondrial dysfunction. In: Santulli G (ed) Mitochondrial dynamics in cardiovascular medicine. Springer International Publishing, Cham, pp 465\u2013520","DOI":"10.1007\/978-3-319-55330-6_25"},{"key":"8834_CR61","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/mds.25032","volume":"28","author":"EC Hirsch","year":"2013","unstructured":"Hirsch EC, Jenner P, Przedborski S (2013) Pathogenesis of Parkinson\u2019s disease. Mov Disord 28:24\u201330. https:\/\/doi.org\/10.1002\/mds.25032","journal-title":"Mov Disord"},{"key":"8834_CR62","doi-asserted-by":"publisher","unstructured":"Labandeira-Garcia JL, Costa-Besada MA, Labandeira CM et al (2017) Insulin-Like growth Factor-1 and neuroinflammation. Front Aging Neurosci 9. https:\/\/doi.org\/10.3389\/fnagi.2017.00365","DOI":"10.3389\/fnagi.2017.00365"},{"key":"8834_CR63","doi-asserted-by":"publisher","first-page":"874","DOI":"10.3390\/ijms20040874","volume":"20","author":"M Maciejczyk","year":"2019","unstructured":"Maciejczyk M, \u017bebrowska E, Chabowski A (2019) Insulin resistance and oxidative stress in the brain: what\u2019s new? Int J Mol Sci 20:874. https:\/\/doi.org\/10.3390\/ijms20040874","journal-title":"Int J Mol Sci"},{"key":"8834_CR64","doi-asserted-by":"publisher","unstructured":"Manfready RA, Engen PA, Verhagen Metman L et al (2021) Attenuated postprandial GLP-1 response in parkinson\u2019s disease. Front Neurosci 15. https:\/\/doi.org\/10.3389\/fnins.2021.660942","DOI":"10.3389\/fnins.2021.660942"},{"key":"8834_CR65","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.drudis.2016.01.013","volume":"21","author":"D Athauda","year":"2016","unstructured":"Athauda D, Foltynie T (2016) The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson\u2019s disease: mechanisms of action. Drug Discov Today 21:802\u2013818. https:\/\/doi.org\/10.1016\/j.drudis.2016.01.013","journal-title":"Drug Discov Today"},{"key":"8834_CR66","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1111\/j.1476-5381.2012.01971.x","volume":"166","author":"I Salcedo","year":"2012","unstructured":"Salcedo I, Tweedie D, Li Y, Greig NH (2012) Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders. Br J Pharmacol 166:1586\u20131599. https:\/\/doi.org\/10.1111\/j.1476-5381.2012.01971.x","journal-title":"Br J Pharmacol"},{"key":"8834_CR67","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ejphar.2015.09.029","volume":"768","author":"Y Chen","year":"2015","unstructured":"Chen Y, Zhang Y, Li L, H\u00f6lscher C (2015) Neuroprotective effects of geniposide in the MPTP mouse model of Parkinson\u2019s disease. Eur J Pharmacol 768:21\u201327. https:\/\/doi.org\/10.1016\/j.ejphar.2015.09.029","journal-title":"Eur J Pharmacol"},{"key":"8834_CR68","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/jnr.21483","volume":"86","author":"G Bertilsson","year":"2008","unstructured":"Bertilsson G, Patrone C, Zachrisson O et al (2008) Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson\u2019s disease. J Neurosci Res 86:326\u2013338. https:\/\/doi.org\/10.1002\/jnr.21483","journal-title":"J Neurosci Res"},{"key":"8834_CR69","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/978-3-642-41199-1_9","volume":"219","author":"X Tian","year":"2014","unstructured":"Tian X, Kang DS, Benovic J (2014) \u03b2-Arrestins and G protein-coupled receptor trafficking. Handb Exp Pharmacol 219:173\u2013186. https:\/\/doi.org\/10.1007\/978-3-642-41199-1_9","journal-title":"Handb Exp Pharmacol"},{"key":"8834_CR70","doi-asserted-by":"publisher","first-page":"6614","DOI":"10.1073\/pnas.0710402105","volume":"105","author":"N Sonoda","year":"2008","unstructured":"Sonoda N, Imamura T, Yoshizaki T et al (2008) \u03b2-Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic \u03b2 cells. Proc Natl Acad Sci U S A 105:6614\u20136619. https:\/\/doi.org\/10.1073\/pnas.0710402105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8834_CR71","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.3390\/cells9071621","volume":"9","author":"A Matarese","year":"2020","unstructured":"Matarese A, Gambardella J, Lombardi A et al (2020) miR-7 regulates GLP-1-Mediated insulin release by targeting \u03b2-Arrestin 1. Cells 9:1621. https:\/\/doi.org\/10.3390\/cells9071621","journal-title":"Cells"},{"key":"8834_CR72","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1172\/JCI73066","volume":"124","author":"M Latreille","year":"2014","unstructured":"Latreille M, Hausser J, St\u00fctzer I et al (2014) MicroRNA-7a regulates pancreatic \u03b2 cell function. J Clin Invest 124:2722\u20132735. https:\/\/doi.org\/10.1172\/JCI73066","journal-title":"J Clin Invest"},{"key":"8834_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-0871-0","volume":"14","author":"KS Kirkley","year":"2017","unstructured":"Kirkley KS, Popichak KA, Afzali MF et al (2017) Microglia amplify inflammatory activation of astrocytes in manganese neurotoxicity. J Neuroinflammation 14:99. https:\/\/doi.org\/10.1186\/s12974-017-0871-0","journal-title":"J Neuroinflammation"},{"key":"8834_CR74","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1002\/mds.23948","volume":"26","author":"MJ Devine","year":"2011","unstructured":"Devine MJ, Gwinn K, Singleton A, Hardy J (2011) Parkinson\u2019s disease and \u03b1-synuclein expression. Mov Disord 26:2160\u20132168. https:\/\/doi.org\/10.1002\/mds.23948","journal-title":"Mov Disord"},{"key":"8834_CR75","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1046\/j.1471-4159.2002.00928.x","volume":"81","author":"H-M Gao","year":"2002","unstructured":"Gao H-M, Jiang J, Wilson B et al (2002) Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson\u2019s disease. J Neurochem 81:1285\u20131297. https:\/\/doi.org\/10.1046\/j.1471-4159.2002.00928.x","journal-title":"J Neurochem"},{"key":"8834_CR76","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1096\/fj.04-2751com","volume":"19","author":"W Zhang","year":"2005","unstructured":"Zhang W, Wang T, Pei Z et al (2005) Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson\u2019s disease. FASEB J 19:533\u2013542. https:\/\/doi.org\/10.1096\/fj.04-2751com","journal-title":"FASEB J"},{"key":"8834_CR77","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1126\/science.1227901","volume":"339","author":"A Aguzzi","year":"2013","unstructured":"Aguzzi A, Barres BA, Bennett ML (2013) Microglia: scapegoat, saboteur, or something else? Science 339:156\u2013161. https:\/\/doi.org\/10.1126\/science.1227901","journal-title":"Science"},{"key":"8834_CR78","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrn2038","volume":"8","author":"ML Block","year":"2007","unstructured":"Block ML, Zecca L, Hong J-S (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8:57\u201369. https:\/\/doi.org\/10.1038\/nrn2038","journal-title":"Nat Rev Neurosci"},{"key":"8834_CR79","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1038\/s41467-020-15267-z","volume":"11","author":"L-P Bernier","year":"2020","unstructured":"Bernier L-P, York EM, Kamyabi A et al (2020) Microglial metabolic flexibility supports immune surveillance of the brain parenchyma. Nat Commun 11:1559. https:\/\/doi.org\/10.1038\/s41467-020-15267-z","journal-title":"Nat Commun"},{"key":"8834_CR80","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/nm.4397","volume":"23","author":"MW Salter","year":"2017","unstructured":"Salter MW, Stevens B (2017) Microglia emerge as central players in brain disease. Nat Med 23:1018\u20131027. https:\/\/doi.org\/10.1038\/nm.4397","journal-title":"Nat Med"},{"key":"8834_CR81","doi-asserted-by":"publisher","unstructured":"Guan Y, Han F (2020) Key mechanisms and potential targets of the NLRP3 inflammasome in neurodegenerative diseases. Front Integr Neurosci 14. https:\/\/doi.org\/10.3389\/fnint.2020.00037","DOI":"10.3389\/fnint.2020.00037"},{"key":"8834_CR82","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13024-016-0094-3","volume":"11","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Lu M, Du R-H et al (2016) MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson\u2019s disease. Mol Neurodegeneration 11:28. https:\/\/doi.org\/10.1186\/s13024-016-0094-3","journal-title":"Mol Neurodegeneration"},{"key":"8834_CR83","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1007\/s00415-022-11491-3","volume":"270","author":"L Soraci","year":"2023","unstructured":"Soraci L, Gambuzza ME, Biscetti L et al (2023) Toll-like receptors and NLRP3 inflammasome-dependent pathways in Parkinson\u2019s disease: mechanisms and therapeutic implications. J Neurol 270:1346\u20131360. https:\/\/doi.org\/10.1007\/s00415-022-11491-3","journal-title":"J Neurol"},{"key":"8834_CR84","doi-asserted-by":"publisher","first-page":"111822","DOI":"10.1016\/j.ejmech.2019.111822","volume":"185","author":"X Zhang","year":"2020","unstructured":"Zhang X, Xu A, Lv J et al (2020) Development of small molecule inhibitors targeting NLRP3 inflammasome pathway for inflammatory diseases. Eur J Med Chem 185:111822. https:\/\/doi.org\/10.1016\/j.ejmech.2019.111822","journal-title":"Eur J Med Chem"},{"key":"8834_CR85","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/mds.26488","volume":"31","author":"P Zhang","year":"2016","unstructured":"Zhang P, Shao X-Y, Qi G-J et al (2016) Cdk5-dependent activation of neuronal inflammasomes in Parkinson\u2019s disease. Mov Disord 31:366\u2013376. https:\/\/doi.org\/10.1002\/mds.26488","journal-title":"Mov Disord"},{"key":"8834_CR86","doi-asserted-by":"publisher","first-page":"744942","DOI":"10.3389\/fnmol.2021.744942","volume":"14","author":"S Li","year":"2022","unstructured":"Li S, Bi G, Han S, Huang R (2022) MicroRNAs play a role in Parkinson\u2019s disease by regulating microglia function: from pathogenetic involvement to therapeutic potential. Front Mol Neurosci 14:744942. https:\/\/doi.org\/10.3389\/fnmol.2021.744942","journal-title":"Front Mol Neurosci"},{"key":"8834_CR87","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2174\/1566523218666180430121323","volume":"18","author":"R Titze-de-Almeida","year":"2024","unstructured":"Titze-de-Almeida R, Titze-de-Almeida SS (2024) Mir-7 replacement therapy in Parkinson\u2019s disease. Curr Gene Ther 18:143\u2013153","journal-title":"Curr Gene Ther"},{"key":"8834_CR88","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3390\/biom13050865","volume":"13","author":"LA Citterio","year":"2023","unstructured":"Citterio LA, Mancuso R, Agostini S et al (2023) Serum and Exosomal miR-7-1-5p and miR-223-3p as possible biomarkers for Parkinson\u2019s disease. Biomolecules 13:865. https:\/\/doi.org\/10.3390\/biom13050865","journal-title":"Biomolecules"},{"key":"8834_CR89","doi-asserted-by":"publisher","first-page":"7057","DOI":"10.1007\/s12035-015-9620-5","volume":"53","author":"Z Fan","year":"2016","unstructured":"Fan Z, Lu M, Qiao C et al (2016) MicroRNA-7 enhances subventricular zone neurogenesis by inhibiting NLRP3\/caspase-1 axis in adult neural stem cells. Mol Neurobiol 53:7057\u20137069. https:\/\/doi.org\/10.1007\/s12035-015-9620-5","journal-title":"Mol Neurobiol"},{"key":"8834_CR90","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/diseases7010022","volume":"7","author":"S Matsuda","year":"2019","unstructured":"Matsuda S, Ikeda Y, Murakami M et al (2019) Roles of PI3K\/AKT\/GSK3 pathway involved in psychiatric illnesses. Diseases 7:22. https:\/\/doi.org\/10.3390\/diseases7010022","journal-title":"Diseases"},{"key":"8834_CR91","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1053\/j.semperi.2014.10.006","volume":"39","author":"RF Hevner","year":"2015","unstructured":"Hevner RF (2015) Brain overgrowth in disorders of RTK\u2013PI3K\u2013AKT signaling: a mosaic of malformations. Semin Perinatol 39:36\u201343. https:\/\/doi.org\/10.1053\/j.semperi.2014.10.006","journal-title":"Semin Perinatol"},{"key":"8834_CR92","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s12640-019-0003-y","volume":"35","author":"SN Rai","year":"2019","unstructured":"Rai SN, Dilnashin H, Birla H et al (2019) The role of PI3K\/Akt and ERK in neurodegenerative disorders. Neurotox Res 35:775\u2013795. https:\/\/doi.org\/10.1007\/s12640-019-0003-y","journal-title":"Neurotox Res"},{"key":"8834_CR93","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/MPH.0000000000000329","volume":"37","author":"D King","year":"2015","unstructured":"King D, Yeomanson D, Bryant HE (2015) PI3king the lock: targeting the PI3K\/Akt\/mTOR pathway as a novel therapeutic strategy in neuroblastoma. J Pediatr Hematol Oncol 37:245. https:\/\/doi.org\/10.1097\/MPH.0000000000000329","journal-title":"J Pediatr Hematol Oncol"},{"key":"8834_CR94","doi-asserted-by":"publisher","first-page":"7455","DOI":"10.1038\/sj.onc.1209085","volume":"24","author":"DA Altomare","year":"2005","unstructured":"Altomare DA, Testa JR (2005) Perturbations of the AKT signaling pathway in human cancer. Oncogene 24:7455\u20137464. https:\/\/doi.org\/10.1038\/sj.onc.1209085","journal-title":"Oncogene"},{"key":"8834_CR95","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1080\/15548627.2015.1043076","volume":"11","author":"X Yu","year":"2015","unstructured":"Yu X, Long YC, Shen H-M (2015) Differential regulatory functions of three classes of phosphatidylinositol and phosphoinositide 3-kinases in autophagy. Autophagy 11:1711\u20131728. https:\/\/doi.org\/10.1080\/15548627.2015.1043076","journal-title":"Autophagy"},{"key":"8834_CR96","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2217\/fnl.12.72","volume":"7","author":"ZZ Chong","year":"2012","unstructured":"Chong ZZ, Shang YC, Wang S, Maiese K (2012) A critical kinase cascade in neurological disorders: PI 3-K, Akt, and mTOR. Future Neurol 7:733\u2013748","journal-title":"Future Neurol"},{"key":"8834_CR97","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante M, Sabatini DM (2012) mTOR signaling in growth control and disease. Cell 149:274\u2013293. https:\/\/doi.org\/10.1016\/j.cell.2012.03.017","journal-title":"Cell"},{"key":"8834_CR98","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.648636","author":"H-Z Long","year":"2021","unstructured":"Long H-Z, Cheng Y, Zhou Z-W et al (2021) PI3K\/AKT signal pathway: a target of natural products in the prevention and treatment of Alzheimer\u2019s disease and Parkinson\u2019s disease. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2021.648636","journal-title":"Front Pharmacol"},{"key":"8834_CR99","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.bcp.2019.02.020","volume":"165","author":"M Arioka","year":"2019","unstructured":"Arioka M, Takahashi-Yanaga F (2019) Glycogen synthase kinase-3 inhibitor as a multi-targeting anti-rheumatoid drug. Biochem Pharmacol 165:207\u2013213. https:\/\/doi.org\/10.1016\/j.bcp.2019.02.020","journal-title":"Biochem Pharmacol"},{"key":"8834_CR100","doi-asserted-by":"publisher","first-page":"571","DOI":"10.7150\/thno.14334","volume":"6","author":"MK Pandey","year":"2016","unstructured":"Pandey MK, DeGrado TR (2016) Glycogen synthase kinase-3 (GSK-3)-targeted therapy and imaging. Theranostics 6:571\u2013593. https:\/\/doi.org\/10.7150\/thno.14334","journal-title":"Theranostics"},{"key":"8834_CR101","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.phrs.2015.03.010","volume":"97","author":"M Golpich","year":"2015","unstructured":"Golpich M, Amini E, Hemmati F et al (2015) Glycogen synthase kinase-3 beta (GSK-3\u03b2) signaling: implications for Parkinson\u2019s disease. Pharmacol Res 97:16\u201326. https:\/\/doi.org\/10.1016\/j.phrs.2015.03.010","journal-title":"Pharmacol Res"},{"key":"8834_CR102","doi-asserted-by":"publisher","unstructured":"Yang L, Wang H, Liu L, Xie A (2018) The role of Insulin\/IGF-1\/PI3K\/Akt\/GSK3\u03b2 signaling in Parkinson\u2019s disease dementia. Front Neurosci 12. https:\/\/doi.org\/10.3389\/fnins.2018.00073","DOI":"10.3389\/fnins.2018.00073"},{"key":"8834_CR103","doi-asserted-by":"publisher","first-page":"7291","DOI":"10.1523\/JNEUROSCI.0625-19.2019","volume":"39","author":"S Luo","year":"2019","unstructured":"Luo S, Kang SS, Wang Z-H et al (2019) Akt phosphorylates NQO1 and triggers its degradation, abolishing its antioxidative activities in Parkinson\u2019s disease. J Neurosci 39:7291\u20137305. https:\/\/doi.org\/10.1523\/JNEUROSCI.0625-19.2019","journal-title":"J Neurosci"},{"key":"8834_CR104","doi-asserted-by":"publisher","first-page":"107900","DOI":"10.1016\/j.neuropharm.2019.107900","volume":"164","author":"RM Salama","year":"2020","unstructured":"Salama RM, Abdel-Latif GA, Abbas SS et al (2020) Neuroprotective effect of Crocin against rotenone-induced Parkinson\u2019s disease in rats: interplay between PI3K\/Akt\/mTOR signaling pathway and enhanced expression of miRNA-7 and miRNA-221. Neuropharmacology 164:107900. https:\/\/doi.org\/10.1016\/j.neuropharm.2019.107900","journal-title":"Neuropharmacology"},{"key":"8834_CR105","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1523\/JNEUROSCI.17-07-02295.1997","volume":"17","author":"JM Conner","year":"1997","unstructured":"Conner JM, Lauterborn JC, Yan Q et al (1997) Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J Neurosci 17:2295\u20132313. https:\/\/doi.org\/10.1523\/JNEUROSCI.17-07-02295.1997","journal-title":"J Neurosci"},{"key":"8834_CR106","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/jnr.21139","volume":"85","author":"T Aid","year":"2007","unstructured":"Aid T, Kazantseva A, Piirsoo M et al (2007) Mouse and rat BDNF gene structure and expression revisited. J Neurosci Res 85:525\u2013535. https:\/\/doi.org\/10.1002\/jnr.21139","journal-title":"J Neurosci Res"},{"key":"8834_CR107","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/978-3-642-45106-5_9","volume":"220","author":"B Lu","year":"2014","unstructured":"Lu B, Nagappan G, Lu Y (2014) BDNF and synaptic plasticity, cognitive function, and dysfunction. Handb Exp Pharmacol 220:223\u2013250. https:\/\/doi.org\/10.1007\/978-3-642-45106-5_9","journal-title":"Handb Exp Pharmacol"},{"key":"8834_CR108","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.3390\/ijms21031170","volume":"21","author":"E Palasz","year":"2020","unstructured":"Palasz E, Wysocka A, Gasiorowska A et al (2020) BDNF as a promising therapeutic agent in Parkinson\u2019s disease. Int J Mol Sci 21:1170. https:\/\/doi.org\/10.3390\/ijms21031170","journal-title":"Int J Mol Sci"},{"key":"8834_CR109","doi-asserted-by":"publisher","unstructured":"Costa R, Perestrelo T, Almeida R (2018) PROneurotrophins and consequences.\u00a0Molecular Neurobiology 55.\u00a0https:\/\/doi.org\/10.1007\/s12035-017-0505-7","DOI":"10.1007\/s12035-017-0505-7"},{"key":"8834_CR110","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.brainresbull.2020.11.005","volume":"166","author":"M Wang","year":"2021","unstructured":"Wang M, Xie Y, Qin D (2021) Proteolytic cleavage of ProBDNF to mBDNF in neuropsychiatric and neurodegenerative diseases. Brain Res Bull 166:172\u2013184. https:\/\/doi.org\/10.1016\/j.brainresbull.2020.11.005","journal-title":"Brain Res Bull"},{"key":"8834_CR111","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/s0959-4388(00)00092-1","volume":"10","author":"DR Kaplan","year":"2000","unstructured":"Kaplan DR, Miller FD (2000) Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol 10:381\u2013391. https:\/\/doi.org\/10.1016\/s0959-4388(00)00092-1","journal-title":"Curr Opin Neurobiol"},{"key":"8834_CR112","doi-asserted-by":"publisher","first-page":"13019","DOI":"10.1074\/jbc.272.20.13019","volume":"272","author":"N Ninkina","year":"1997","unstructured":"Ninkina N, Grashchuck M, Buchman VL, Davies AM (1997) TrkB variants with deletions in the leucine-rich motifs of the extracellular domain. J Biol Chem 272:13019\u201313025. https:\/\/doi.org\/10.1074\/jbc.272.20.13019","journal-title":"J Biol Chem"},{"key":"8834_CR113","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1002\/j.1460-2075.1996.tb00698.x","volume":"15","author":"C Strohmaier","year":"1996","unstructured":"Strohmaier C, Carter BD, Urfer R et al (1996) A splice variant of the neurotrophin receptor TrkB with increased specificity for brain-derived neurotrophic factor. EMBO J 15:3332\u20133337. https:\/\/doi.org\/10.1002\/j.1460-2075.1996.tb00698.x","journal-title":"EMBO J"},{"key":"8834_CR114","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s10571-017-0510-4","volume":"38","author":"P Kowia\u0144ski","year":"2018","unstructured":"Kowia\u0144ski P, Lietzau G, Czuba E et al (2018) BDNF: A key factor with multipotent impact on brain signaling and synaptic plasticity. Cell Mol Neurobiol 38:579\u2013593. https:\/\/doi.org\/10.1007\/s10571-017-0510-4","journal-title":"Cell Mol Neurobiol"},{"key":"8834_CR115","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S0028-3908(02)00043-6","volume":"42","author":"H Xiong","year":"2002","unstructured":"Xiong H, Futamura T, Jourdi H et al (2002) Neurotrophins induce BDNF expression through the glutamate receptor pathway in neocortical neurons. Neuropharmacology 42:903\u2013912","journal-title":"Neuropharmacology"},{"key":"8834_CR116","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1177\/1073858417697037","volume":"23","author":"J Gibon","year":"2017","unstructured":"Gibon J, Barker PA (2017) Neurotrophins and proneurotrophins: focus on synaptic activity and plasticity in the brain. Neuroscientist 23:587\u2013604. https:\/\/doi.org\/10.1177\/1073858417697037","journal-title":"Neuroscientist"},{"key":"8834_CR117","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1038\/ncomms3490","volume":"4","author":"A Anastasia","year":"2013","unstructured":"Anastasia A, Deinhardt K, Chao MV et al (2013) Val66Met polymorphism of BDNF alters prodomain structure to induce neuronal growth cone Retraction. Nat Commun 4:2490. https:\/\/doi.org\/10.1038\/ncomms3490","journal-title":"Nat Commun"},{"key":"8834_CR118","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nrn1726","volume":"6","author":"B Lu","year":"2005","unstructured":"Lu B, Pang PT, Woo NH (2005) The Yin and Yang of neurotrophin action. Nat Rev Neurosci 6:603\u2013614. https:\/\/doi.org\/10.1038\/nrn1726","journal-title":"Nat Rev Neurosci"},{"key":"8834_CR119","doi-asserted-by":"publisher","first-page":"6888","DOI":"10.1523\/JNEUROSCI.20-18-06888.2000","volume":"20","author":"B Xu","year":"2000","unstructured":"Xu B, Gottschalk W, Chow A et al (2000) The role of brain-derived neurotrophic factor receptors in the mature hippocampus: modulation of long-term potentiation through a presynaptic mechanism involving TrkB. J Neurosci 20:6888\u20136897. https:\/\/doi.org\/10.1523\/JNEUROSCI.20-18-06888.2000","journal-title":"J Neurosci"},{"key":"8834_CR120","doi-asserted-by":"publisher","first-page":"237","DOI":"10.14670\/HH-25.237","volume":"25","author":"T Numakawa","year":"2010","unstructured":"Numakawa T, Suzuki S, Kumamaru E et al (2010) BDNF function and intracellular signaling in neurons. Histol Histopathol 25:237\u2013258. https:\/\/doi.org\/10.14670\/HH-25.237","journal-title":"Histol Histopathol"},{"key":"8834_CR121","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s13577-017-0187-5","volume":"31","author":"D Li","year":"2018","unstructured":"Li D, Yang H, Ma J et al (2018) MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson\u2019s disease by targeting Nlrp3. Hum Cell 31:106\u2013115. https:\/\/doi.org\/10.1007\/s13577-017-0187-5","journal-title":"Hum Cell"},{"key":"8834_CR122","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s10571-010-9523-y","volume":"30","author":"Y Yuan","year":"2010","unstructured":"Yuan Y, Sun J, Zhao M et al (2010) Overexpression of alpha-synuclein down-regulates BDNF expression. Cell Mol Neurobiol 30:939\u2013946. https:\/\/doi.org\/10.1007\/s10571-010-9523-y","journal-title":"Cell Mol Neurobiol"},{"key":"8834_CR123","doi-asserted-by":"publisher","first-page":"549","DOI":"10.4103\/1673-5374.205084","volume":"12","author":"TB Sampaio","year":"2017","unstructured":"Sampaio TB, Savall AS, Gutierrez MEZ, Pinton S (2017) Neurotrophic factors in Alzheimer\u2019s and Parkinson\u2019s diseases: implications for pathogenesis and therapy. Neural Regen Res 12:549. https:\/\/doi.org\/10.4103\/1673-5374.205084","journal-title":"Neural Regen Res"},{"key":"8834_CR124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omtn.2022.05.037","volume":"29","author":"Q Cao","year":"2022","unstructured":"Cao Q, Luo S, Yao W et al (2022) Suppression of abnormal \u03b1-synuclein expression by activation of BDNF transcription ameliorates Parkinson\u2019s disease-like pathology. Mol Ther Nucleic Acids 29:1. https:\/\/doi.org\/10.1016\/j.omtn.2022.05.037","journal-title":"Mol Ther Nucleic Acids"},{"key":"8834_CR125","doi-asserted-by":"publisher","first-page":"10773","DOI":"10.1073\/pnas.1713969114","volume":"114","author":"SS Kang","year":"2017","unstructured":"Kang SS, Zhang Z, Liu X et al (2017) TrkB neurotrophic activities are blocked by \u03b1-synuclein, triggering dopaminergic cell death in Parkinson\u2019s disease. Proc Natl Acad Sci U S A 114:10773\u201310778. https:\/\/doi.org\/10.1073\/pnas.1713969114","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8834_CR126","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3233\/JPD-201981","volume":"11","author":"M Borsche","year":"2021","unstructured":"Borsche M, Pereira SL, Klein C, Gr\u00fcnewald A (2021) Mitochondria and Parkinson\u2019s disease: clinical, molecular, and translational aspects. J Parkinson\u2019s Disease 11:45\u201360. https:\/\/doi.org\/10.3233\/JPD-201981","journal-title":"J Parkinson\u2019s Disease"},{"key":"8834_CR127","doi-asserted-by":"crossref","unstructured":"Srinivasan E, Chandrasekhar G, Chandrasekar P et al (2021) Alpha-Synuclein aggregation in Parkinson\u2019s disease. Front Med 8","DOI":"10.3389\/fmed.2021.736978"},{"key":"8834_CR128","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/s41593-022-01140-3","volume":"25","author":"ML Choi","year":"2022","unstructured":"Choi ML, Chappard A, Singh BP et al (2022) Pathological structural conversion of \u03b1-synuclein at the mitochondria induces neuronal toxicity. Nat Neurosci 25:1134\u20131148. https:\/\/doi.org\/10.1038\/s41593-022-01140-3","journal-title":"Nat Neurosci"},{"key":"8834_CR129","doi-asserted-by":"publisher","first-page":"10814","DOI":"10.1074\/jbc.M110.132514","volume":"286","author":"V Choubey","year":"2011","unstructured":"Choubey V, Safiulina D, Vaarmann A et al (2011) Mutant A53T \u03b1-Synuclein Induces Neuronal Death by Increasing Mitochondrial Autophagy*. J Biol Chem 286:10814\u201310824. https:\/\/doi.org\/10.1074\/jbc.M110.132514","journal-title":"J Biol Chem"},{"key":"8834_CR130","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.neulet.2009.02.056","volume":"454","author":"G Liu","year":"2009","unstructured":"Liu G, Zhang C, Yin J et al (2009) -synuclein is differentially expressed in mitochondria from different rat brain regions and dose-dependently down-regulates complex i activity. Neurosci Lett 454:187\u2013192. https:\/\/doi.org\/10.1016\/j.neulet.2009.02.056","journal-title":"Neurosci Lett"},{"key":"8834_CR131","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s40478-019-0696-4","volume":"7","author":"X Wang","year":"2019","unstructured":"Wang X, Becker K, Levine N et al (2019) Pathogenic alpha-synuclein aggregates preferentially bind to mitochondria and affect cellular respiration. Acta Neuropathol Commun 7:41. https:\/\/doi.org\/10.1186\/s40478-019-0696-4","journal-title":"Acta Neuropathol Commun"},{"key":"8834_CR132","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1093\/cvr\/cvr349","volume":"93","author":"SM Davidson","year":"2012","unstructured":"Davidson SM, Yellon DM, Murphy MP, Duchen MR (2012) Slow calcium waves and redox changes precede mitochondrial permeability transition pore opening in the intact heart during hypoxia and reoxygenation. Cardiovasc Res 93:445\u2013453. https:\/\/doi.org\/10.1093\/cvr\/cvr349","journal-title":"Cardiovasc Res"},{"key":"8834_CR133","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0143-4160(97)90062-2","volume":"22","author":"MV Zamaraeva","year":"1997","unstructured":"Zamaraeva MV, Hagelgans AI, Abramov AY et al (1997) Ionophoretic properties of ferutinin. Cell Calcium 22:235\u2013241. https:\/\/doi.org\/10.1016\/S0143-4160(97)90062-2","journal-title":"Cell Calcium"},{"key":"8834_CR134","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.neurobiolaging.2013.11.008","volume":"35","author":"LJ Martin","year":"2014","unstructured":"Martin LJ, Semenkow S, Hanaford A, Wong M (2014) The mitochondrial permeability transition pore regulates Parkinson\u2019s disease development in mutant \u03b1-synuclein transgenic mice. Neurobiol Aging 35:1132\u20131152. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.11.008","journal-title":"Neurobiol Aging"},{"key":"8834_CR135","doi-asserted-by":"publisher","first-page":"21742","DOI":"10.1074\/jbc.M113.451815","volume":"288","author":"I Prots","year":"2013","unstructured":"Prots I, Veber V, Brey S et al (2013) <article-title update=\"added\">\u03b1-Synuclein Oligomers Impair Neuronal Microtubule-Kinesin Interplay. J Biol Chem 288:21742\u201321754. https:\/\/doi.org\/10.1074\/jbc.M113.451815","journal-title":"J Biol Chem"},{"key":"8834_CR136","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.jmb.2007.03.063","volume":"369","author":"RP Gon\u00e7alves","year":"2007","unstructured":"Gon\u00e7alves RP, Buzhynskyy N, Prima V et al (2007) Supramolecular assembly of VDAC in native mitochondrial outer membranes. J Mol Biol 369:413\u2013418. https:\/\/doi.org\/10.1016\/j.jmb.2007.03.063","journal-title":"J Mol Biol"},{"key":"8834_CR137","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1006\/jsbi.1997.3954","volume":"121","author":"CA Mannella","year":"1998","unstructured":"Mannella CA (1998) Conformational changes in the mitochondrial channel protein, VDAC, and their functional implications. J Struct Biol 121:207\u2013218. https:\/\/doi.org\/10.1006\/jsbi.1997.3954","journal-title":"J Struct Biol"},{"key":"8834_CR138","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nrn1868","volume":"7","author":"PM Abou-Sleiman","year":"2006","unstructured":"Abou-Sleiman PM, Muqit MMK, Wood NW (2006) Expanding insights of mitochondrial dysfunction in Parkinson\u2019s disease. Nat Rev Neurosci 7:207\u2013219. https:\/\/doi.org\/10.1038\/nrn1868","journal-title":"Nat Rev Neurosci"},{"key":"8834_CR139","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0304-4157(94)90004-3","volume":"1197","author":"R Benz","year":"1994","unstructured":"Benz R (1994) Permeation of hydrophilic solutes through mitochondrial outer membranes: review on mitochondrial porins. Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes 1197:167\u2013196. https:\/\/doi.org\/10.1016\/0304-4157(94)90004-3","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes"},{"key":"8834_CR140","doi-asserted-by":"publisher","first-page":"6483","DOI":"10.1074\/jbc.M115.691352","volume":"291","author":"AD Chaudhuri","year":"2016","unstructured":"Chaudhuri AD, Choi DC, Kabaria S et al (2016) MicroRNA-7 regulates the function of mitochondrial permeability transition pore by targeting VDAC1 expression. J Biol Chem 291:6483\u20136493. https:\/\/doi.org\/10.1074\/jbc.M115.691352","journal-title":"J Biol Chem"},{"key":"8834_CR141","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.2174\/138161211798072508","volume":"17","author":"SM Cardoso","year":"2011","unstructured":"Cardoso SM (2011) The mitochondrial cascade hypothesis for Parkinson\u2019s disease. Curr Pharm Des 17:3390\u20133397. https:\/\/doi.org\/10.2174\/138161211798072508","journal-title":"Curr Pharm Des"},{"key":"8834_CR142","doi-asserted-by":"publisher","first-page":"5256","DOI":"10.1523\/JNEUROSCI.0984-06.2006","volume":"26","author":"PM Keeney","year":"2006","unstructured":"Keeney PM, Xie J, Capaldi RA, Bennett JP (2006) Parkinson\u2019s disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J Neurosci 26:5256\u20135264. https:\/\/doi.org\/10.1523\/JNEUROSCI.0984-06.2006","journal-title":"J Neurosci"},{"key":"8834_CR143","doi-asserted-by":"publisher","first-page":"21490","DOI":"10.1074\/jbc.M113.545749","volume":"289","author":"ES Luth","year":"2014","unstructured":"Luth ES, Stavrovskaya IG, Bartels T et al (2014) Soluble, prefibrillar \u03b1-synuclein oligomers promote complex I-dependent, Ca2+-induced mitochondrial dysfunction*. J Biol Chem 289:21490\u201321507. https:\/\/doi.org\/10.1074\/jbc.M113.545749","journal-title":"J Biol Chem"},{"key":"8834_CR144","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/0006-291X(89)91141-8","volume":"163","author":"Y Mizuno","year":"1989","unstructured":"Mizuno Y, Ohta S, Tanaka M et al (1989) Deficiencies in complex I subunits of the respiratory chain in Parkinson\u2019s disease. Biochem Biophys Res Commun 163:1450\u20131455. https:\/\/doi.org\/10.1016\/0006-291X(89)91141-8","journal-title":"Biochem Biophys Res Commun"},{"key":"8834_CR145","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.brainres.2007.10.061","volume":"1189","author":"WD Parker","year":"2008","unstructured":"Parker WD, Parks JK, Swerdlow RH (2008) Complex I deficiency in Parkinson\u2019s disease frontal cortex. Brain Res 1189:215\u2013218. https:\/\/doi.org\/10.1016\/j.brainres.2007.10.061","journal-title":"Brain Res"},{"key":"8834_CR146","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","volume":"54","author":"AHV Schapira","year":"1990","unstructured":"Schapira AHV, Cooper JM, Dexter D et al (1990) Mitochondrial Complex I Deficiency in Parkinson\u2019s Disease. J Neurochem 54:823\u2013827. https:\/\/doi.org\/10.1111\/j.1471-4159.1990.tb02325.x","journal-title":"J Neurochem"},{"key":"8834_CR147","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1016\/j.febslet.2015.10.021","volume":"589","author":"D Haddad","year":"2015","unstructured":"Haddad D, Nakamura K (2015) Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson\u2019s disease. FEBS Lett 589:3702\u20133713. https:\/\/doi.org\/10.1016\/j.febslet.2015.10.021","journal-title":"FEBS Lett"},{"key":"8834_CR148","doi-asserted-by":"publisher","first-page":"e7049108","DOI":"10.1155\/2016\/7049108","volume":"2016","author":"Y Mu\u00f1oz","year":"2016","unstructured":"Mu\u00f1oz Y, Carrasco CM, Campos JD et al (2016) Parkinson\u2019s Disease: The Mitochondria-Iron Link. Parkinson\u2019s Disease 2016:e7049108. https:\/\/doi.org\/10.1155\/2016\/7049108","journal-title":"Parkinson\u2019s Disease"},{"key":"8834_CR149","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1038\/s41418-020-0542-z","volume":"27","author":"PR Angelova","year":"2020","unstructured":"Angelova PR, Choi ML, Berezhnov AV et al (2020) Alpha synuclein aggregation drives ferroptosis: an interplay of iron, calcium and lipid peroxidation. Cell Death Differ 27:2781\u20132796. https:\/\/doi.org\/10.1038\/s41418-020-0542-z","journal-title":"Cell Death Differ"},{"key":"8834_CR150","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.neulet.2017.09.065","volume":"661","author":"G Je","year":"2017","unstructured":"Je G, Kim Y-S (2017) Mitochondrial ROS-mediated post-transcriptional regulation of \u03b1-synuclein through miR-7 and miR-153. Neurosci Lett 661:132\u2013136. https:\/\/doi.org\/10.1016\/j.neulet.2017.09.065","journal-title":"Neurosci Lett"},{"key":"8834_CR151","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.3390\/biomedicines11051349","volume":"11","author":"BFS Guedes","year":"2023","unstructured":"Guedes BFS, Cardoso SM, Esteves AR (2023) The impact of MicroRNAs on mitochondrial function and immunity: relevance to Parkinson\u2019s disease. Biomedicines 11:1349. https:\/\/doi.org\/10.3390\/biomedicines11051349","journal-title":"Biomedicines"},{"issue":"1","key":"8834_CR152","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/jnc.13731","volume":"139","author":"A Bose","year":"2016","unstructured":"Bose A, Beal MF (2016) Mitochondrial dysfunction in Parkinson\u2019s disease. J Neurochem 139(1):216\u2013231. https:\/\/doi.org\/10.1111\/jnc.13731","journal-title":"J Neurochem"},{"key":"8834_CR153","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s00221-016-4836-9","volume":"235","author":"TQ Melo","year":"2017","unstructured":"Melo TQ, van Zomeren KC, Ferrari MFR et al (2017) Impairment of mitochondria dynamics by human A53T \u03b1-synuclein and rescue by NAP (davunetide) in a cell model for Parkinson\u2019s disease. Exp Brain Res 235:731\u2013742. https:\/\/doi.org\/10.1007\/s00221-016-4836-9","journal-title":"Exp Brain Res"},{"key":"8834_CR154","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.neulet.2018.05.009","volume":"678","author":"DC Choi","year":"2018","unstructured":"Choi DC, Yoo M, Kabaria S, Junn E (2018) Microrna-7 facilitates the degradation of alpha-Synuclein and its aggregates by promoting autophagy. Neurosci Lett 678:118\u2013123. https:\/\/doi.org\/10.1016\/j.neulet.2018.05.009","journal-title":"Neurosci Lett"},{"key":"8834_CR155","doi-asserted-by":"publisher","first-page":"e1743183","DOI":"10.1155\/2019\/1743183","volume":"2019","author":"L Zhao","year":"2019","unstructured":"Zhao L, Wang Z (2019) MicroRNAs: game changers in the regulation of \u03b1-Synuclein in parkinson\u2019s disease. Parkinson\u2019s Disease 2019:e1743183. https:\/\/doi.org\/10.1155\/2019\/1743183","journal-title":"Parkinson\u2019s Disease"},{"key":"8834_CR156","doi-asserted-by":"publisher","first-page":"8161","DOI":"10.1073\/pnas.0609874104","volume":"104","author":"C Perier","year":"2007","unstructured":"Perier C, Bov\u00e9 J, Wu D-C et al (2007) Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson\u2019s disease. Proc Natl Acad Sci U S A 104:8161\u20138166. https:\/\/doi.org\/10.1073\/pnas.0609874104","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8834_CR157","doi-asserted-by":"publisher","unstructured":"Fragkouli A, Doxakis E (2014) miR-7 and miR-153 protect neurons against MPP+-induced cell death via upregulation of mTOR pathway. Front Cell Neurosci 8. https:\/\/doi.org\/10.3389\/fncel.2014.00182","DOI":"10.3389\/fncel.2014.00182"},{"key":"8834_CR158","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1002\/hep.25576","volume":"55","author":"Y Fang","year":"2012","unstructured":"Fang Y, Xue J-L, Shen Q et al (2012) MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase\/Akt pathway in hepatocellular carcinoma. Hepatology 55:1852\u20131862. https:\/\/doi.org\/10.1002\/hep.25576","journal-title":"Hepatology"},{"key":"8834_CR159","doi-asserted-by":"publisher","first-page":"3566","DOI":"10.1158\/0008-5472.CAN-07-6639","volume":"68","author":"B Kefas","year":"2008","unstructured":"Kefas B, Godlewski J, Comeau L et al (2008) Microrna-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res 68:3566\u20133572. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-6639","journal-title":"Cancer Res"},{"key":"8834_CR160","doi-asserted-by":"publisher","first-page":"12425","DOI":"10.1074\/jbc.M114.625962","volume":"290","author":"AD Chaudhuri","year":"2015","unstructured":"Chaudhuri AD, Kabaria S, Choi DC et al (2015) Microrna-7 promotes glycolysis to protect against 1-Methyl-4-phenylpyridinium-induced cell death. J Biol Chem 290:12425\u201312434. https:\/\/doi.org\/10.1074\/jbc.M114.625962","journal-title":"J Biol Chem"},{"key":"8834_CR161","doi-asserted-by":"publisher","first-page":"12725","DOI":"10.1523\/JNEUROSCI.0985-14.2014","volume":"34","author":"DC Choi","year":"2014","unstructured":"Choi DC, Chae Y-J, Kabaria S et al (2014) Microrna-7 protects against 1-Methyl-4-Phenylpyridinium-Induced cell death by targeting RelA. J Neurosci 34:12725\u201312737. https:\/\/doi.org\/10.1523\/JNEUROSCI.0985-14.2014","journal-title":"J Neurosci"},{"key":"8834_CR162","doi-asserted-by":"publisher","first-page":"e0194300","DOI":"10.1371\/journal.pone.0194300","volume":"13","author":"D-X Han","year":"2018","unstructured":"Han D-X, Xiao Y, Wang C-J et al (2018) Regulation of FSH expression by differentially expressed miR-186-5p in rat anterior adenohypophyseal cells. PLoS ONE 13:e0194300. https:\/\/doi.org\/10.1371\/journal.pone.0194300","journal-title":"PLoS ONE"},{"key":"8834_CR163","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature11993","volume":"495","author":"TB Hansen","year":"2013","unstructured":"Hansen TB, Jensen TI, Clausen BH et al (2013) Natural RNA circles function as efficient microRNA sponges. Nature 495:384\u2013388. https:\/\/doi.org\/10.1038\/nature11993","journal-title":"Nature"},{"key":"8834_CR164","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-018-0454-8","volume":"9","author":"K Zeng","year":"2018","unstructured":"Zeng K, Chen X, Xu M et al (2018) CircHIPK3 promotes colorectal cancer growth and metastasis by sponging miR-7. Cell Death Dis 9:1\u201315. https:\/\/doi.org\/10.1038\/s41419-018-0454-8","journal-title":"Cell Death Dis"},{"key":"8834_CR165","doi-asserted-by":"publisher","first-page":"5597","DOI":"10.26355\/eurrev_201809_15824","volume":"22","author":"X-D Zhang","year":"2018","unstructured":"Zhang X-D, Fan Q-Y, Qiu Z, Chen S (2018) MiR-7 alleviates secondary inflammatory response of microglia caused by cerebral hemorrhage through inhibiting TLR4 expression. Eur Rev Med Pharmacol Sci 22:5597\u20135604. https:\/\/doi.org\/10.26355\/eurrev_201809_15824","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"8834_CR166","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1002\/glia.23153","volume":"65","author":"Q He","year":"2017","unstructured":"He Q, Wang Q, Yuan C, Wang Y (2017) Downregulation of miR-7116-5p in microglia by MPP\u2009+\u2009sensitizes TNF-\u03b1 production to induce dopaminergic neuron damage. Glia 65:1251\u20131263. https:\/\/doi.org\/10.1002\/glia.23153","journal-title":"Glia"},{"key":"8834_CR167","doi-asserted-by":"publisher","unstructured":"Han Y, Yao Y, Wen X et al (2025) Nanodiamond-mediated delivery of microRNA-7 for the neuroprotection of dopaminergic neurons. Front Bioeng Biotechnol 12. https:\/\/doi.org\/10.3389\/fbioe.2024.1480573","DOI":"10.3389\/fbioe.2024.1480573"},{"key":"8834_CR168","doi-asserted-by":"publisher","first-page":"865139","DOI":"10.3389\/fnins.2022.865139","volume":"16","author":"L Wu","year":"2022","unstructured":"Wu L, Xu Q, Zhou M et al (2022) Plasma miR-153 and miR-223 levels as potential biomarkers in Parkinson\u2019s disease. Front Neurosci 16:865139. https:\/\/doi.org\/10.3389\/fnins.2022.865139","journal-title":"Front Neurosci"},{"key":"8834_CR169","doi-asserted-by":"publisher","first-page":"5411","DOI":"10.1038\/s41598-017-03887-3","volume":"7","author":"X Bai","year":"2017","unstructured":"Bai X, Tang Y, Yu M et al (2017) Downregulation of blood serum MicroRNA 29 family in patients with Parkinson\u2019s disease. Sci Rep 7:5411. https:\/\/doi.org\/10.1038\/s41598-017-03887-3","journal-title":"Sci Rep"},{"key":"8834_CR170","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/mds.27928","volume":"35","author":"S Ravanidis","year":"2020","unstructured":"Ravanidis S, Bougea A, Papagiannakis N et al (2020) Circulating Brain-enriched MicroRNAs for detection and discrimination of idiopathic and genetic Parkinson\u2019s disease. Mov Disord 35:457\u2013467. https:\/\/doi.org\/10.1002\/mds.27928","journal-title":"Mov Disord"},{"key":"8834_CR171","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/mds.27542","volume":"34","author":"C Starhof","year":"2019","unstructured":"Starhof C, Hejl A-M, Heegaard NHH et al (2019) The biomarker potential of cell-free MicroRNA from cerebrospinal fluid in parkinsonian syndromes. Mov Disord 34:246\u2013254. https:\/\/doi.org\/10.1002\/mds.27542","journal-title":"Mov Disord"},{"key":"8834_CR172","doi-asserted-by":"publisher","first-page":"68","DOI":"10.4103\/2229-3485.179431","volume":"7","author":"AF Christopher","year":"2016","unstructured":"Christopher AF, Kaur RP, Kaur G et al (2016) MicroRNA therapeutics: discovering novel targets and developing specific therapy. Perspect Clin Res 7:68\u201374. https:\/\/doi.org\/10.4103\/2229-3485.179431","journal-title":"Perspect Clin Res"},{"key":"8834_CR173","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nchembio.118","volume":"4","author":"AL Hopkins","year":"2008","unstructured":"Hopkins AL (2008) Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 4:682\u2013690. https:\/\/doi.org\/10.1038\/nchembio.118","journal-title":"Nat Chem Biol"},{"key":"8834_CR174","doi-asserted-by":"publisher","first-page":"5918","DOI":"10.1039\/C7SC02153D","volume":"8","author":"R McCall","year":"2017","unstructured":"McCall R, Miles M, Lascuna P et al (2017) Dual targeting of the cancer antioxidant network with 1,4-naphthoquinone fused Gold(I) N-heterocyclic carbene complexes. Chem Sci 8:5918\u20135929. https:\/\/doi.org\/10.1039\/C7SC02153D","journal-title":"Chem Sci"},{"key":"8834_CR175","doi-asserted-by":"crossref","unstructured":"Wang Z (2011) The guideline of the design and validation of MiRNA mimics. In: Wu W (ed) MicroRNA and cancer: methods and protocols. Humana, Totowa, NJ, pp 211\u2013223","DOI":"10.1007\/978-1-60761-863-8_15"},{"key":"8834_CR176","doi-asserted-by":"publisher","unstructured":"O\u2019Brien J, Hayder H, Zayed Y, Peng C (2018) Overview of MicroRNA Biogenesis, mechanisms of Actions, and circulation. Front Endocrinol 9. https:\/\/doi.org\/10.3389\/fendo.2018.00402","DOI":"10.3389\/fendo.2018.00402"},{"key":"8834_CR177","doi-asserted-by":"publisher","first-page":"7167","DOI":"10.3390\/ijms23137167","volume":"23","author":"PTB Ho","year":"2022","unstructured":"Ho PTB, Clark IM, Le LTT (2022) MicroRNA-based diagnosis and therapy. Int J Mol Sci 23:7167. https:\/\/doi.org\/10.3390\/ijms23137167","journal-title":"Int J Mol Sci"},{"key":"8834_CR178","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1089\/nat.2011.0328","volume":"22","author":"TO Kabilova","year":"2012","unstructured":"Kabilova TO, Meschaninova MI, Venyaminova AG et al (2012) Short double-stranded RNA with immunostimulatory activity: sequence dependence. Nucleic Acid Ther 22:196\u2013204. https:\/\/doi.org\/10.1089\/nat.2011.0328","journal-title":"Nucleic Acid Ther"},{"key":"8834_CR179","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nn.3113","volume":"15","author":"SM Lehmann","year":"2012","unstructured":"Lehmann SM, Kr\u00fcger C, Park B et al (2012) An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nat Neurosci 15:827\u2013835. https:\/\/doi.org\/10.1038\/nn.3113","journal-title":"Nat Neurosci"},{"key":"8834_CR180","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1007\/s11095-011-0608-1","volume":"28","author":"S Singh","year":"2011","unstructured":"Singh S, Narang AS, Mahato RI (2011) Subcellular fate and off-target effects of siRNA, shRNA, and MiRNA. Pharm Res 28:2996\u20133015. https:\/\/doi.org\/10.1007\/s11095-011-0608-1","journal-title":"Pharm Res"},{"key":"8834_CR181","first-page":"311","volume":"9","author":"A Jackson","year":"2010","unstructured":"Jackson A, Linsley PS (2010) The therapeutic potential of MicroRNA modulation. Discov Med 9:311\u2013318","journal-title":"Discov Med"},{"key":"8834_CR182","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1021\/bi401677d","volume":"53","author":"S Kumar","year":"2014","unstructured":"Kumar S, Mapa K, Maiti S (2014) Understanding the effect of locked nucleic acid and 2\u2019-O-methyl modification on the hybridization thermodynamics of a miRNA-mRNA pair in the presence and absence of AfPiwi protein. Biochemistry 53:1607\u20131615. https:\/\/doi.org\/10.1021\/bi401677d","journal-title":"Biochemistry"},{"key":"8834_CR183","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.gene.2005.12.031","volume":"372","author":"UA \u00d8rom","year":"2006","unstructured":"\u00d8rom UA, Kauppinen S, Lund AH (2006) LNA-modified oligonucleotides mediate specific inhibition of MicroRNA function. Gene 372:137\u2013141. https:\/\/doi.org\/10.1016\/j.gene.2005.12.031","journal-title":"Gene"},{"key":"8834_CR184","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nmeth1079","volume":"4","author":"MS Ebert","year":"2007","unstructured":"Ebert MS, Neilson JR, Sharp PA (2007) MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 4:721\u2013726. https:\/\/doi.org\/10.1038\/nmeth1079","journal-title":"Nat Methods"},{"key":"8834_CR185","doi-asserted-by":"publisher","unstructured":"Perkins DO, Jeffries CD, Jarskog LF, et al (2007) microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biology 8:R27 https:\/\/doi.org\/10.1186\/gb-2007-8-2-r27","DOI":"10.1186\/gb-2007-8-2-r27"},{"key":"8834_CR186","doi-asserted-by":"publisher","unstructured":"Beveridge NJ, Gardiner E, Carroll AP, et al (2010) Schizophrenia is associated with an increase in cortical microRNA biogenesis. Mol Psychiatry 15:1176\u20131189 https:\/\/doi.org\/10.1038\/mp.2009.84","DOI":"10.1038\/mp.2009.84"},{"key":"8834_CR187","doi-asserted-by":"publisher","unstructured":"Kim AH, Reimers M, Maher B, et al (2010) MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorders. Schizophr Res 124:183\u2013191 https:\/\/doi.org\/10.1016\/j.schres.2010.07.002","DOI":"10.1016\/j.schres.2010.07.002"},{"key":"8834_CR188","doi-asserted-by":"publisher","unstructured":"Sun X, Zhang J, Niu W, et al (2015) A preliminary analysis of microRNA as potential clinical biomarker for schizophrenia. Am J Med Genet B Neuropsychiatr Genet 168B:170\u2013178 https:\/\/doi.org\/10.1002\/ajmg.b.32292","DOI":"10.1002\/ajmg.b.32292"},{"key":"8834_CR189","doi-asserted-by":"publisher","unstructured":"Abu-Elneel K, Liu T, Gazzaniga FS, et al (2008) Heterogeneous dysregulation of microRNAs across the autism spectrum. Neurogenetics 9:153\u2013161 https:\/\/doi.org\/10.1007\/s10048-008-0133-5","DOI":"10.1007\/s10048-008-0133-5"},{"key":"8834_CR190","doi-asserted-by":"publisher","unstructured":"Abdelrahman AH, Eid OM, Ibrahim MH, et al (2021) Evaluation of circulating miRNAs and mRNAs expression patterns in autism spectrum disorder. Egyptian Journal of Medical Human Genetics 22:81 https:\/\/doi.org\/10.1186\/s43042-021-00202-8","DOI":"10.1186\/s43042-021-00202-8"},{"key":"8834_CR191","doi-asserted-by":"publisher","unstructured":"Sehovic E, Spahic L, Smajlovic-Skenderagic L, et al (2020) Identification of developmental disorders including autism spectrum disorder using salivary miRNAs in children from Bosnia and Herzegovina. PLOS ONE 15:e0232351 https:\/\/doi.org\/10.1371\/journal.pone.0232351","DOI":"10.1371\/journal.pone.0232351"},{"key":"8834_CR192","doi-asserted-by":"publisher","unstructured":"Hicks SD, Ignacio C, Gentile K, Middleton FA (2016) Salivary miRNA profiles identify children with autism spectrum disorder, correlate with adaptive behavior, and implicate ASD candidate genes involved in neurodevelopment. BMC Pediatr 16:52 https:\/\/doi.org\/10.1186\/s12887-016-0586-x","DOI":"10.1186\/s12887-016-0586-x"},{"key":"8834_CR193","doi-asserted-by":"publisher","unstructured":"Bot AM, D\u0119bski KJ, Lukasiuk K (2013) Alterations in miRNA Levels in the Dentate Gyrus in Epileptic Rats. PLOS ONE 8:e76051 https:\/\/doi.org\/10.1371\/journal.pone.0076051","DOI":"10.1371\/journal.pone.0076051"},{"key":"8834_CR194","doi-asserted-by":"publisher","unstructured":"McKiernan RC, Jimenez-Mateos EM, Sano T, et al (2012) Expression profiling the microRNA response to epileptic preconditioning identifies miR184 as a modulator of seizure-induced neuronal death. Exp Neurol 237:346\u2013354 https:\/\/doi.org\/10.1016\/j.expneurol.2012.06.029","DOI":"10.1016\/j.expneurol.2012.06.029"},{"key":"8834_CR195","doi-asserted-by":"publisher","unstructured":"Sanek NA, Young WS (2024) Investigating the In Vivo Expression Patterns of miR-7 microRNA Family Members in the Adult Mouse Brain. MicroRNA 1:11\u201318 https:\/\/doi.org\/10.2174\/2211536611201010011","DOI":"10.2174\/2211536611201010011"},{"key":"8834_CR196","doi-asserted-by":"publisher","unstructured":"Amar L, Benoit C, Beaumont G, et al (2012) MicroRNA expression profiling of hypothalamic arcuate and paraventricular nuclei from single rats using Illumina sequencing technology. Journal of Neuroscience Methods 209:134\u2013143 https:\/\/doi.org\/10.1016\/j.jneumeth.2012.05.033","DOI":"10.1016\/j.jneumeth.2012.05.033"},{"key":"8834_CR197","doi-asserted-by":"publisher","unstructured":"Mehta SL, Chokkalla AK, Bathula S, et al (2023) CDR1as regulates \u03b1-synuclein-mediated ischemic brain damage by controlling miR-7 availability. Molecular Therapy Nucleic Acids 31:57\u201367 https:\/\/doi.org\/10.1016\/j.omtn.2022.11.022","DOI":"10.1016\/j.omtn.2022.11.022"},{"key":"8834_CR198","doi-asserted-by":"publisher","unstructured":"Luo B, Li L, Song X-D, et al (2024) MicroRNA-7 attenuates secondary brain injury following experimental intracerebral hemorrhage via inhibition of NLRP3. Journal of Stroke and Cerebrovascular Diseases 33:107670 https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2024.107670","DOI":"10.1016\/j.jstrokecerebrovasdis.2024.107670"},{"key":"8834_CR199","doi-asserted-by":"publisher","unstructured":"Sang Q, Liu X, Wang L, et al (2018) CircSNCA downregulation by pramipexole treatment mediates cell apoptosis and autophagy in Parkinson\u2019s disease by targeting miR-7. Aging (Albany NY) 10:1281\u20131293 https:\/\/doi.org\/10.18632\/aging.101466","DOI":"10.18632\/aging.101466"},{"key":"8834_CR200","doi-asserted-by":"publisher","unstructured":"\u00d8rom UA, Kauppinen S, Lund AH (2006) LNA-modified oligonucleotides mediate specific inhibition of microRNA function. Gene, 372, 137\u2013141 https:\/\/doi.org\/10.1016\/j.gene.2005.12.031","DOI":"10.1016\/j.gene.2005.12.031"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-08834-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-08834-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-08834-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T06:36:24Z","timestamp":1774074984000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-026-08834-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,28]]},"references-count":200,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["8834"],"URL":"https:\/\/doi.org\/10.1007\/s10072-026-08834-7","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,28]]},"assertion":[{"value":"6 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"310"}}